Twitter Facebook LinkedIn YouTube

Tree of Knowledge International has completed the acquisition of Asterion Bio Med Inc.

Video Platform Video Management Video Solutions Video Player

Asterion is a healthcare leader in the ethical and controlled use of medical cannabis operating under the banner; Toronto Poly Clinic, which manages more than 4,800 cannabis patients.

Additional Information:

Company: Tree of Knowledge International
Website: http://www.tokicorp.ca
Stock Symbol: CSE: TOKI
Date Published: Dec 20, 2018
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

Tree of Knowledge International has completed the acquisition of Asterion Bio Med Inc.

Asterion is a healthcare leader in the ethical and controlled use of medical cannabis operating under the banner; Toronto Poly Clinic, which manages more than 4,800 cannabis patients.

Through an exclusive strategic alliance agreement with Jack Nathan Medical Inc., which operates over 70 Jack Nathan Health medical clinics in six provinces across Canada, Asterion has access to one of the largest healthcare systems across Canada for its education and research platform, with over 1.5 million patient visits annually.

The company issued approximately 96.7 million shares to the shareholders of Asterion.

Tree of Knowledge produces and sells hemp-based CBD products in certain jurisdictions in the United States, as well as in Europe, South America and China, which may be used in connection with the treatment of a number of ailments and for general wellness purposes

The company offers several CBD products containing EVR Premium Hemp Oil, which is organically grown and handled, gluten-free, vegan, and non-GMO derived from U.S. Department of Agriculture approved industrial hemp grown in the United States.

Jean-Paul Gaillard, CEO, stated: "Coming from the Tobacco and consumer products industries, I feel very strongly about the need for data and empirical evidence to drive our product development and commercial strategy. By acquiring Asterion, our combined company is now armed with the elements we need to execute our mission to develop, expand, and commercialize our portfolio of cannabinoid natural health and therapeutic consumer products using data driven insight. In pursuing our goals, we intend to leverage our globally recognized pain expertise, our exclusive strategic alliance with Jack Nathan Medical Inc., and our international clinic platforms that provide key insight from millions of consumers and patients each year.”

Dr Kevin Rod, Chief Medical Officer, added: "Statistically significant data regarding the efficacy of natural health and therapeutic products using cannabinoids is still nascent. We feel we have been in a unique position to rigorously document and gather this type of data through observational results we have witnessed over the past several years at Asterion’s Toronto Poly Clinics."

The company recently closed a private placement, raising gross proceeds of $2.74 million from the sale of approximately 12.5 million units priced at $0.22 per unit.

Each unit consisted of 1 share and 1 warrant, with each warrant exercisable at $0.39 for 48 months, subject to an acceleration clause.

The shares started trading on the Canadian Securities Exchange in July and are currently trading at $0.18.

For more information, please visit the company’s website www.tokicorp.ca, contact Michael Caridi, CEO, at 917-295-1374, or email michael@tok.ca

I’m Samantha Deutscher for Investmentpitch Media